Congress · 117th Congress
FDA finds more problems with Johnson & Johnson contractor
The company was originally scheduled to produce 62 million vaccines by May, according to the delivery schedule spelled out in Johnson & Johnson’s $1 billion contact with the Biomedical Advanced Research